Literature DB >> 30244128

Silencing of FTS increases radiosensitivity by blocking radiation-induced Notch1 activation and spheroid formation in cervical cancer cells.

D S Prabakaran1, Sridhar Muthusami2, T Sivaraman3, Jae-Ran Yu4, Woo-Yoon Park5.   

Abstract

Increasing evidence(s) suggests that cancer stem cells (CSC) in tumours contribute to radio-resistance and recurrence. Notch plays an important role in the maintenance of CSC in many cancers including cervical cancer. Previously, we have reported the role of Fused Toes Homolog (FTS) in conferring radioresistance in cervical cancer cells in vitro and human subjects. The present study investigated the regulatory role of FTS in Notch signaling and maintenance of CSC upon irradiation of cervical cancer cells. The expression of Notch1, 2, 3, cleaved Notch1 and its downstream target Hes1, and spheroid formation was increased by irradiation. Silencing of FTS prevented the radiation-induced increase in the expression of Notch signaling molecules and spheroid formation. Immunoprecipitation showed FTS binds Notch1 and Hes1. Also in silico structural analysis identified putative residues responsible for the binding between FTS and Notch1. Spheroid formation and the expression of CSC markers, Nanog, Oct4A and Sox2 were greatly reduced by combining silencing of FTS and radiation. Taken together, these results suggest that FTS is involved in the regulation of irradiation-induced Notch signaling and CSC activation and can be used as a target to increase radiosensitivity in cervical cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Cervical cancer; Fused Toes Homolog; Notch; Radiation

Mesh:

Substances:

Year:  2018        PMID: 30244128     DOI: 10.1016/j.ijbiomac.2018.09.114

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  9 in total

1.  NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells.

Authors:  Elia Farah; Chaohao Li; Lijun Cheng; Yifan Kong; Nadia A Lanman; Pete Pascuzzi; Gabrielle Renee Lorenz; Yanquan Zhang; Nihal Ahmad; Lang Li; Tim Ratliff; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2019-04-02       Impact factor: 5.157

2.  Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.

Authors:  Lili Song; Shikai Liu; Sufen Zhao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 3.  Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.

Authors:  He-Ming Zhou; Ji-Gang Zhang; Xue Zhang; Qin Li
Journal:  Signal Transduct Target Ther       Date:  2021-02-15

4.  Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.

Authors:  Md Imtiaz Khalil; Christopher Madere; Ishita Ghosh; Rosalyn M Adam; Arrigo De Benedetti
Journal:  Pathophysiology       Date:  2021-07-20

Review 5.  Notch signaling in female cancers: a multifaceted node to overcome drug resistance.

Authors:  Maria V Giuli; Angelica Mancusi; Eugenia Giuliani; Isabella Screpanti; Saula Checquolo
Journal:  Cancer Drug Resist       Date:  2021-08-05

6.  Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.

Authors:  Prabakaran D S; Pankaj Kumar Chaturvedi; Dineshkumar Krishnamoorthy; Young-Seok Seo; Mallikarjuna Thippana; Woo-Yoon Park
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.240

7.  Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.

Authors:  Zhangquan Shen; Yang Wu; Guijun He
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 8.  The Cellular and Molecular Immunotherapy in Prostate Cancer.

Authors:  Anirban Goutam Mukherjee; Uddesh Ramesh Wanjari; D S Prabakaran; Raja Ganesan; Kaviyarasi Renu; Abhijit Dey; Balachandar Vellingiri; Sabariswaran Kandasamy; Thiyagarajan Ramesh; Abilash Valsala Gopalakrishnan
Journal:  Vaccines (Basel)       Date:  2022-08-22

9.  Identification of crucial genes and pathways associated with colorectal cancer by bioinformatics analysis.

Authors:  Xiaoqun Liu; Xiangdong Liu; Tiankui Qiao; Wei Chen
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.